[Ca2+ sensitizers].
Endoh
M
M
Department of Pharmacology, Yamagata University School of Medicine, Japan. mendou@med.id.yamagata-u.ac.jp
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002316:Cardiotonic Agents; D000242:Cyclic AMP / Q000502:physiology; D004095:Dihydropyridines / Q000494:pharmacology / Q000627:therapeutic use; D015195:Drug Design; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology / Q000627:therapeutic use; D009206:Myocardium / Q000378:metabolism; D011724:Pyridazines / Q000494:pharmacology / Q000627:therapeutic use; D015398:Signal Transduction; D000077464:Simendan
D002316:Cardiotonic Agents; D004095:Dihydropyridines; D006835:Hydrazones; D011724:Pyridazines; C115124:Sch 00013; D000077464:Simendan; C041648:pimobendan; D000242:Cyclic AMP; D002118:Calcium